PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Cancer-inflammation 'vicious cycle' detailed in new study

2015-04-20
(Press-News.org) PHILADELPHIA, April 20, 2015 - New findings hidden within the complex machinery behind the vicious cycle of chronic inflammation and cancer are presented today by researchers from the University of Pittsburgh Cancer Institute, partner with UPMC Cancer Center, at the American Association for Cancer Research (AACR) Annual Meeting in Philadelphia.

The research is funded by the National Institutes of Health (NIH) and Fondazione RiMED, of Palermo, Italy.

Inflammation is an important immune system tool that helps the body rid itself of foreign invaders, such as bacteria. However, chronic inflammation can fuel tumor growth by facilitating formation of cancer blood vessels, supplying nutrients and setting cancerous cells free to colonize other parts of the body.

The basic research into the specific mechanisms promoting cancer inflammation is a critical step in the development of drugs that could interrupt this process.

"In the last 20 years we've recognized that chronic inflammation and cancer are connected - long-term inflammation leads to the development of dysplasia and tumor progression," said lead author Sandra Cascio, Ph.D., a research associate in Pitt's Department of Immunology. "Recently, scientists have provided detailed insights into molecules and cellular pathways linking inflammation and cancer. In our study, we found a new mechanism that had previously escaped us."

The mechanism is driven by a complex of MUC1, a molecule long studied in the laboratory of senior author and Pitt immunologist Olivera Finn, Ph.D., and p65, a molecule belonging to a protein complex family known to be activated in inflammation.

Dr. Cascio, in collaboration with Dr. Finn, looked for MUC1/p65-mediated epigenetic modifications affecting inflammatory genes. Epigenetics refers to outside factors that modify the activity of a gene, but do not cause a more obvious genetic mutation. Sure enough, the researchers discovered that this complex, which they found specifically in cancer cells, was causing DNA to be transcribed differently than expected.

"Normally MUC1 is covered in sugar molecules, like leaves cover a tree in spring," said Dr. Cascio. "When it is made by a tumor, it lacks sugar and is more like a tree in fall. Our research shows that this form of MUC1 associates with p65 and regulates transcription of pro-inflammatory cytokine genes in tumor cells. This leads to the recruitment of inflammatory cells into the tumor site. Inflammatory cells, including macrophages, produce additional cytokines that enhance the activity of MUC1 and p65, establishing a continuous positive feedback loop, or a vicious circle, resulting in tumor progression."

In order to pinpoint this altered pro-inflammatory mechanism in cancer cells, Dr. Cascio and her team combed through more than 20 types of epigenetic modifications and 300 factors that allow for the remodeling of chromatin, which are macromolecules in cells that control gene expression and DNA replication.

Specifically, the researchers found that MUC1 and p65 involve an enzyme called the Enhancer of Zeste homolog 2, or EzH2, known to induce epigenetic modifications, in order to prompt chromatin remodeling on cytokine gene promoters.

"Developing drugs that could keep these genes from being improperly turned on and off could interrupt this cancer-inflammation process and stop the tumor growth and spread," said Dr. Cascio. "It's a promising avenue for future exploration."

INFORMATION:

Joshua Sciurba, B.S., of Pitt at the time of this research, also participated in this work.

This research was funded by Fondazione RiMED and NIH National Cancer Institute grant CA56103.

About UPCI As the only NCI-designated comprehensive cancer center in western Pennsylvania, UPCI is a recognized leader in providing innovative cancer prevention, detection, diagnosis, and treatment; bio-medical research; compassionate patient care and support; and community-based outreach services. Investigators at UPCI, a partner with UPMC CancerCenter, are world-renowned for their work in clinical and basic cancer research.

http://www.upmc.com/media



ELSE PRESS RELEASES FROM THIS DATE:

Oldest fossils controversy resolved

2015-04-20
New analysis of world-famous 3.46 billion-year-old rocks by researchers from the University of Bristol, the University of Oxford and UWA (the University of Western Australia) is set to finally resolve a long running evolutionary controversy. The new research, published this week in Proceedings of the National Academy of Sciences USA, shows that structures once thought to be Earth's oldest microfossils do not compare with younger fossil candidates but have, instead, the character of peculiarly shaped minerals. In 1993, US scientist Bill Schopf described tiny carbon-rich ...

Deep national history of immigration predicts wide cultural comfort displaying emotion

2015-04-20
MADISON, Wis. -- If your home country is historically heterogeneous and you know it, crack a smile. People who live in countries built on centuries of migration from a wide range of other countries are more emotionally expressive than people in more insular cultures, according to research led by University of Wisconsin-Madison psychology Professor Paula Niedenthal. The study, published this week in the Proceedings of the National Academy of Sciences, compared several social and demographic variables to the way people describe the rules for displaying emotion in dozens ...

Researchers produce first atlas of airborne microbes across United States

2015-04-20
A University of Colorado Boulder and North Carolina State University-led team has produced the first atlas of airborne microbes across the continental U.S., a feat that has implications for better understanding health and disease in humans, animals and crops. The researchers collected outdoor dust samples from roughly 1,200 homes in all 50 states from both urban and rural areas using a powerful DNA sequencing technique to identify specific bacteria and fungal species. While standard, culture-based surveys are able to detect only a handful of different species, the high-tech ...

Uranium isotopes carry the fingerprint of ancient bacterial activity

2015-04-20
The oceans and other water bodies contain billions of tons of dissolved uranium. Over the planet's history, some of this uranium was transformed into an insoluble form, causing it to precipitate and accumulate in sediments. There are two ways that uranium can go from a soluble to an insoluble form: either through the action of live organisms - bacteria - or by interacting chemically with certain minerals. Knowing which pathway was taken can provide valuable insight into the evolution and activity of microbial biology over Earth's history. Publishing in the journal PNAS, ...

Study shows early environment has a lasting impact on stress response systems

2015-04-20
New University of Washington research finds that children's early environments have a lasting impact on their responses to stress later in life, and that the negative effects of deprived early environments can be mitigated -- but only if that happens before age 2. Published April 20 in the Proceedings of the National Academy of Sciences, the research is believed to be the first to identify a sensitive period during early life when children's stress response systems are particularly likely to be influenced by their caregiving environments. "The early environment has ...

Study: Soil nutrients may limit ability of plants to slow climate change

2015-04-20
MISSOULA - Many scientists assume that the growing level of carbon dioxide in the atmosphere will accelerate plant growth. However, a new study co-written by University of Montana researchers suggests much of this growth will be curtailed by limited soil nutrients. The end result: By the end of the century, there may be more than an additional 10 percent of CO2 in the atmosphere, which would accelerate climate change. "If society stays on its current trajectory of CO2 emissions and the growth rates of plants don't increase as much as many models project, the result by ...

Study re-examines sports restrictions for children with heart rhythm disorder

2015-04-20
Sports participation may be safer than previously thought for children with the heart rhythm disorder long QT syndrome, and authors of a new study in JACC: Clinical Electrophysiology say restrictions should be eased to allow appropriately treated children with the condition to participate more in recreational and competitive sports. "Re-examining participation rules is important because the physiologic benefits of exercise at all ages have been emphasized repeatedly and promoted as a national public health agenda," said Peter Aziz, M.D., lead author of the study and ...

Study compares outcomes of 2 devices used in carotid artery stenting

2015-04-20
WASHINGTON (April 20, 2015) - A study published today in JACC: Cardiovascular Interventions showed that in-hospital and 30-day stroke or death rates were equally low when using either a distal filter EPD (F-EPD) or a proximal EPD (P-EPD) to protect patients from blood clots during carotid artery stenting, but a small sample size for one device raises questions on the study's ability to detect potentially meaningful differences in outcomes. The Centers for Medicare and Medicaid Services mandates that cardiologists use one of these two devices in order to be reimbursed ...

Two different carotid artery stenting procedures show little difference in effectiveness

2015-04-20
PHILADELPHIA - Use of either proximal embolic protection devices (P-EPDs) or distal filter embolic protection devices (F-EPDs) during elective carotid artery stenting results in low rates of in-hospital stroke and death, according to a new study from researchers at the Perelman School of Medicine at the University of Pennsylvania. The study, published in JACC: Cardiovascular Interventions, found that although P-EPDs have been theorized to be more effective than F-EPDs at preventing stroke during carotid artery stenting, this first comparative effectiveness study revealed ...

Extending natalizumab up to 8 weeks shown safe and effective in patients with MS

2015-04-20
In a study of 1,964 patients with multiple sclerosis (MS) led by researchers at the NYU Langone Multiple Sclerosis Comprehensive Care Center, extending the dose of natalizumab from 4 weeks up to 8 weeks was shown to be well-tolerated and effective in patients, and resulted in no cases of the potentially fatal side effect progressive multifocal leukoencephalopathy (PML). The drug showed similar efficacy in treating disease activity among patients, according to the study led by Lana Zhovtis-Ryerson, MD, an assistant professor of neurology at the NYU Langone Multiple Sclerosis ...

LAST 30 PRESS RELEASES:

Quantitative study assesses how gender and race impact young athletes’ perceptions of their coaches

Enzymes open new path to universal donor blood

Gemini south reveals origin of unexpected differences in giant binary stars

Hornets found to be primary pollinators of two Angelica species

Aspirin vs placebo as adjuvant therapy for breast cancer

Association of new-onset seizures with SARS-CoV-2 vaccines

How can forests be reforested in a climate-friendly way?

More plants on the menu of ancient hunter-gatherers

The aspirin conundrum: navigating negative results, age, aging dynamics and equity

Cancer screening rates are significantly lower in US federally qualified health centers

Nature's nudge: Study shows green views lead to healthier food choices

AI algorithms can determine how well newborns nurse, study shows

Scientists develop new organoid model to study thymus function

A revised classification of primary iron overload syndromes

Expanding health equity by including nursing home residents in clinical trials

Identification and exploration of transcripts involved in antibiotic resistance mechanism of two critical superbugs

Quantum fiber optics in the brain enhance processing, may protect against degenerative diseases

Icahn School of Medicine at Mount Sinai names Miriam Merad, MD, PhD, as Dean for Translational Research and Therapeutic Innovation

Details of hurricane Ian’s aftermath captured with new remote sensing method

Robots can’t outrun animals. A new study explores why

The Human Immunome Project unveils scientific plan to decode and model the immune system

New research funding awarded to assess the role of race in predicting heart disease

Exploring the role of seven key genes in breast cancer: insights from in silico and in vitro analyses

The therapeutic effects of baicalein on the hepatopulmonary syndrome in the rat model of chronic common bile duct ligation

Development and characterization of honey-containing nanoemulsion for topical delivery

Decoding cellular ‘shape-shifters’

"Seeing the invisible": new tech enables deep tissue imaging during surgery

After 25 years, researchers uncover genetic cause of rare neurological disease

Probing the effects of interplanetary space on asteroid Ryugu

T. rex not as smart as previously claimed, scientists find

[Press-News.org] Cancer-inflammation 'vicious cycle' detailed in new study